Mobile Health Technology for the Personalized Therapy of Hemophilia

The management of patients with hemophilia has evolved significantly since the first treatment attempts were made in the late 1930s. Since then, each new step in the treatment of patients with hemophilia has brought important advancements, as well as its unique set of challenges. Today, a patient-ce...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in medicine Vol. 8; p. 711973
Main Authors:	Dirzu, Noemi, Hotea, Ionut, Jitaru, Ciprian, Brinza, Melen, Urian, Laura, Peters, Mareike-Catrina, Gal, Krisztina, Popescu, Louis, Blag, Cristina, Marian, Mirela, Pal, Eva, Stanescu, Marilena, Cenariu, Diana, Tarniceriu, Cristina, Serban, Margit, Dima, Delia, Coriu, Daniel, Tomuleasa, Ciprian
Format:	Journal Article
Language:	English
Published:	Frontiers Media S.A 10-08-2021
Subjects:	application monitoring hemophilia IT technology Medicine mHealth patient-tailored monitoring
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The management of patients with hemophilia has evolved significantly since the first treatment attempts were made in the late 1930s. Since then, each new step in the treatment of patients with hemophilia has brought important advancements, as well as its unique set of challenges. Today, a patient-centered, individualized comprehensive approach is the new paradigm, moving away from the traditional “one size-fits-all” approach, to provide the best possible care for each patient with a bleeding disorder. As part of this complex task, mobile health applications might have the capacity to play an important role in reaching that goal. However, the use of new electronic technologies as part of a comprehensive treatment approach for patients with hemophilia simultaneously presents a new set of challenges that needs consideration. In the first section, currently available treatment of hemophilia patients will be revised, while in the second part the role of IT software in the treatment monitoring of hemophilia patients will be discussed.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 This article was submitted to Hematology, a section of the journal Frontiers in Medicine These authors have contributed equally to this work and share first authorship Reviewed by: Albert Farrugia, University of Western Australia, Australia; Magdy El Ekiaby, Independent Researcher, Giza, Egypt; Jean-Claude Faber, LCT LuxConsulTrans, Luxembourg Edited by: Thierry Burnouf, Taipei Medical University, Taiwan
ISSN:	2296-858X 2296-858X
DOI:	10.3389/fmed.2021.711973